Efficacy of uterine artery embolisation for treatment of symptomatic fibroids and adenomyosis - an interim report on an Australian experience

Liang E, Eisen Liang, Bevan Brown, Brown B, Rodney Kirsop, Kirsop R, Paul Stewart, P. Stewart, Stewart P, Stuart A, Andrew Stuart
The Australian & New Zealand journal of obstetrics & gynaecology · 2012 · vol. 52(2) , pp. 106–112 · doi:10.1111/j.1479-828x.2011.01399.x · PMID:22221154 · W2156680878
Other OA: closed CC0 ⤵ 15 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This Australian audit found uterine artery embolisation to be a safe and highly effective treatment for symptomatic fibroids and adenomyosis, with high rates of symptom improvement and significant volume reductions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Uterine artery embolisation (UAE) has been widely described internationally, however there is a paucity of data reported from Australia. AIM: To conduct a local audit on the efficacy and safety of UAE treating symptomatic fibroids and adenomyosis. METHODS: Clinical data of 76 consecutive UAEs were reviewed. Degree of fibroid-related symptoms before embolisation and at follow-up visits were compared. Procedural and subsequent complications were recorded. Uterine and fibroid volumes were measured on MRI at baseline and six months post-UAE. RESULTS: Seventy-six UAEs were performed in 75 women. Fifty-nine women had follow-up duration of more than six months, and one woman was lost to follow-up. Clinical success was 93% overall (n = 59) and 96% for menorrhagia (n = 49). For dysmenorrhoea (n = 36), 89% of women had at least some improvement, 75% had significant improvement and 56% had resolution of pain. For urinary symptoms (n = 32), 97% of women had at least some improvement and 50% had resolution of all urinary symptoms. Adenomyosis was found in 17 (29%) women treated. The primary success rate was 96%, and secondary success rate (after repeat UAE) was 100%. MRI showed 50% uterine volume reduction and 60% dominant fibroid volume reduction. There were no significant procedural-related acute complications. There were three possible cases of endometritis, two managed conservatively and one required hysterectomy. CONCLUSIONS: This audit, based on local Australian experience, has confirmed that UAE is a safe and highly effective treatment for women with symptomatic fibroids and/or adenomyosis.

My notes (saved in your browser only)

Condition tags

dysmenorrheaendometriosisadenomyosis

MeSH descriptors

Endometriosis Leiomyoma Uterine Artery Embolization Uterine Artery Embolization Adult Adult Australia Australia Clinical Audit Clinical Audit Dysmenorrhea Dysmenorrhea Dysmenorrhea Endometriosis Endometriosis Female Female Follow-Up Studies Follow-Up Studies Humans

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (17)

Cited by (16)

Source provenance

europepmc
last seen: 2026-10-20T06:13:28.455750+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-10-08T21:09:51.187616+00:00
unpaywall
last seen: 2026-10-20T06:27:24.728081+00:00
License: CC0 · commercial use OK